Cargando…
Advances in immunopharmacology : proceedings of the First International Conference on Immunopharmacology, July 1980, Brighton, England /
Advances in Immunopharmacology documents the proceedings of the First International Conference on Immunopharmacology held in Brighton, England, in July 1980. The volume contains 60 papers organized into 10 parts. The papers in Part I examine the pharmacology of immunotherapeutic drugs and immunotoxi...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico Congresos, conferencias eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford ; New York :
Pergamon Press,
1981.
|
| Edición: | 1st ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn732916864 | ||
| 003 | OCoLC | ||
| 005 | 20231117044607.0 | ||
| 006 | m o d | ||
| 007 | cr bn||||||abp | ||
| 007 | cr bn||||||ada | ||
| 008 | 110624s1981 enka o 101 0 eng d | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d OCLCQ |d UIU |d OCLCF |d OCLCQ |d OCLCO |d N$T |d E7B |d NLGGC |d EBLCP |d HEBIS |d OCL |d OCLCQ |d YDXCP |d OCLCQ |d OCLCA |d MERUC |d OCLCO |d STF |d OCLCQ |d OCLCO |d OCLCA |d OCLCQ |d UKAHL |d OCLCQ |d VLY |d OCLCQ |d OCLCO |d COM |d OCLCO |d OCLCQ |d OCL |d OCLCA |d OCLCO | ||
| 066 | |c (S | ||
| 019 | |a 760974551 |a 896795317 |a 974618262 |a 974660507 |a 1100937292 |a 1162417739 |a 1187184764 |a 1397481550 | ||
| 020 | |a 9781483145396 |q (electronic bk.) | ||
| 020 | |a 1483145395 |q (electronic bk.) | ||
| 020 | |z 0080263844 |q (hardcover) | ||
| 020 | |z 9780080263847 |q (hardcover) | ||
| 020 | |z 0080279740 |q (flexicover) | ||
| 020 | |z 9780080279749 |q (flexicover) | ||
| 035 | |a (OCoLC)732916864 |z (OCoLC)760974551 |z (OCoLC)896795317 |z (OCoLC)974618262 |z (OCoLC)974660507 |z (OCoLC)1100937292 |z (OCoLC)1162417739 |z (OCoLC)1187184764 |z (OCoLC)1397481550 | ||
| 042 | |a dlr | ||
| 050 | 4 | |a QR186 |b .I54 1980 | |
| 060 | 4 | |a W3 IN181W 1st 1980a |a [QW 940 I61 1980a] | |
| 070 | |a QR186.I57 |b 1981 | ||
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615/.7 |2 19 |
| 111 | 2 | |a International Conference on Immunopharmacology |n (1st : |d 1980 : |c Brighton, Sussex) | |
| 245 | 1 | 0 | |a Advances in immunopharmacology : |b proceedings of the First International Conference on Immunopharmacology, July 1980, Brighton, England / |c editors, J. Hadden [and others]. |
| 250 | |a 1st ed. | ||
| 260 | |a Oxford ; |a New York : |b Pergamon Press, |c 1981. | ||
| 300 | |a 1 online resource (ix, 517 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2011. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2011 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 588 | 0 | |a Print version record. | |
| 504 | |a REFERENCESChapter 6. Assessment of Immunotoxicity Induced by the Environmental Chemicals 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Diethylstilbestrol and Benzo (a) pyrene; ABSTRACT; INTRODUCTION; MATERIALS AND METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 7. On the Heterogeneity of Immunotherapeutic Agents; ABSTRACT; KEYWORDS; INTRODUCTION; THE EFFECT OF CYTOTOXIC IMMUNODEPRESSANTS ON IMMUNOCYTE SUBPOPULATIONS; SOME OPEN PROBLEMS IN THE CHARACTERIZATION OF IMMUNOSTIMULANTS; ACKNOWLEDGMENT; REFERENCES; Part 2: Thymic Hormones. | ||
| 505 | 0 | |a Front Cover; Advances in Immunopharmacology; Copyright Page; Table of Contents; Part 1: Pharmacology of Immunotherapeuti Drugs and Immunotoxicology; Chapter 1. Immuno-enhancement and Drug Elimination Kinetics In Vivo; ABSTRACT; KEYWORDS; INTRODUCTION; HUMAN STUDIES; MOUSE STUDIES; REFERENCES; Chapter 2. Immunostimulants and Hepatic Drug Metabolism; ABSTRACT; KEYWORDS; INTRODUCTION; INFLUENCE OF C. PARVUM ON DRUG METABOLISM; RELATION OF ANTITUMOR ACTIVITY TO DEPRESSION OF DRUG METABOLISM; MECHANISM OF ACTION OF C. PARVUM; HUMORAL FACTORS; ACKNOWLEDGEMENT; REFERENCES. | |
| 505 | 8 | |6 880-01 |a Chapter 8. A Multifaceted Role forThymosin and its Composite Peptides in T-Cell RegulationABSTRACT; KEYWORDS; INTRODUCTION; THYMOSIN AND ITS COMPONENT PEPTIDES; BIOLOGY OF THE THYMOSINS; CLINICAL TRIALS WITH THYMOSIN; SUMMARY AND PERSPECTIVES; ACKNOWLEDGEMENT; REFERENCES; Chapter 9. The Effect of the Serum Thymic Factor (FTS) on Suppressor T Cells; SUPPRESSION OF CELL-MEDIATED CYTOTOXICITY; INHIBITION OF SKIN GRAFT REJECTION (Bach, 1977; SUPPRESSION OF MOLONEY VIRUS INDUCED SARCOMA IMMUNE RESPONSES; SUPPRESSION OF ANTIBODY FORMATION IN NZB MICE; PREVENTION OF AUTOIMMUNITY IN NZB AND B/W MICE. | |
| 505 | 8 | |a IN VITRO RESTORATION OF SUPPRESSOR FUNCTION IN HUMAN LUPUSDISCUSSION AND CONCLUSIONS; REFERENCES; Chapter 10. The Influence of Thymic Humoral Factor on Immunoproliferative Disorders and Viral Infections in Humans; ABSTRACT; KEYWORDS; INTRODUCTION; MATERIALS AND METHODS; RESULTS AND DISCUSSION; CONCLUSIONS; REFERENCES; Part 3: Immunopharmacologic Approaches to Diseasesother than Cancer; Chapter 11. Virus Induced Immunomodulation; INTERACTION OF MICROBES WITH THE IMMUNE SYSTEM; FRIEND LEUKEMIA VIRUS INDUCED IMMUNOSUPPRESSION; DISCUSSION AND CONCLUSIONS; SUMMARY; REFERENCES. | |
| 520 | |a Advances in Immunopharmacology documents the proceedings of the First International Conference on Immunopharmacology held in Brighton, England, in July 1980. The volume contains 60 papers organized into 10 parts. The papers in Part I examine the pharmacology of immunotherapeutic drugs and immunotoxicology. Part II presents studies on thymic hormones. Part III is devoted to immunopharmacologic approaches to diseases other than cancer. Part IV deals with mechanisms of chemotaxis degranulation and microbicidal action. Part V focuses on cancer immunopharmacology and immunotherapy while Part VI cov. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Immunopharmacology |v Congresses. | |
| 650 | 0 | |a Immunotherapy |x Congresses. | |
| 650 | 0 | |a Immune response |x Congresses. | |
| 650 | 0 | |a Immunosuppression. | |
| 650 | 0 | |a Immunotherapy. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 2 | |a Immunosuppression Therapy |0 (DNLM)D007165 | |
| 650 | 2 | |a Immunotherapy |0 (DNLM)D007167 | |
| 650 | 2 | |a Pharmacology |0 (DNLM)D010600 | |
| 650 | 2 | |a Immune Tolerance |0 (DNLM)D007108 | |
| 650 | 6 | |a Immunoth�erapie |0 (CaQQLa)201-0067406 |x Congr�es. |0 (CaQQLa)201-0378208 | |
| 650 | 6 | |a R�eaction immunitaire |0 (CaQQLa)201-0013536 |x Congr�es. |0 (CaQQLa)201-0378208 | |
| 650 | 6 | |a Immunopharmacologie |0 (CaQQLa)201-0072475 |v Congr�es. |0 (CaQQLa)201-0378219 | |
| 650 | 6 | |a Immunosuppression. |0 (CaQQLa)201-0028044 | |
| 650 | 6 | |a Immunoth�erapie. |0 (CaQQLa)201-0067406 | |
| 650 | 6 | |a Pharmacologie. |0 (CaQQLa)201-0007219 | |
| 650 | 7 | |a pharmacology. |2 aat |0 (CStmoGRI)aat300137970 | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Pharmacology |2 fast |0 (OCoLC)fst01060259 | |
| 650 | 7 | |a Immunotherapy |2 fast |0 (OCoLC)fst00968044 | |
| 650 | 7 | |a Immunosuppression |2 fast |0 (OCoLC)fst00968033 | |
| 650 | 7 | |a Immune response |2 fast |0 (OCoLC)fst00967867 | |
| 650 | 7 | |a Immunopharmacology |2 fast |0 (OCoLC)fst00968030 | |
| 650 | 7 | |a Immunod�epression |x Congr�es comme sujet. |2 fmesh | |
| 650 | 7 | |a Immunoth�erapie |x Congr�es comme sujet. |2 fmesh | |
| 655 | 2 | |a Congress |0 (DNLM)D016423 | |
| 655 | 7 | |a proceedings (reports) |2 aat |0 (CStmoGRI)aatgf300027316 | |
| 655 | 7 | |a Conference papers and proceedings |2 fast |0 (OCoLC)fst01423772 | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congr�es. |2 rvmgf |0 (CaQQLa)RVMGF-000001049 | |
| 700 | 1 | |a Hadden, John W., |d 1939- | |
| 776 | 0 | 8 | |i Print version: |a International Conference on Immunopharmacology (1st : 1980 : Brighton, Sussex). |t Advances in immunopharmacology. |b 1st ed. |d Oxford ; New York : Pergamon Press, 1981 |w (DLC) 80042270 |w (OCoLC)8453110 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780080263847 |z Texto completo |
| 880 | 8 | |6 505-01/(S |a Chapter 3. Effects of Interferon Inducers and Viral Infection on the Metabolism of DrugsABSTRACT; KEYWORDS; ACKNOWLEDGEMENT; REFERENCES; Chapter 4. The Pharmacologic Properties of Various Forms of Interferon; ABSTRACT; KEYWORDS; INTRODUCTION; ISOLATION OF HuIFN-α SUBTYPES; PHARMACOKINETIC COMPARISONS OF HUMAN INTERFERON-ALPHA SUBTYPES; DISCUSSION; ACKNOWLEDGEMENT; REFERENCES; Chapter 5. The Pharmacokinetics of Immunoregulating Drugs: Immunopharmacokinetics; ABSTRACT; INTRODUCTION; PREDNISOLONE/PREDNISONE; AZATHI0PRINE/6-MERCAPT0PURINE; CYCLOPHOSPHAMIDE; IMMUNOSTIMULANTS; ACKNOWLEDGEMENT. | |